Compare Organon Pharma Indonesia Tbk. (SCPI) vs Wijaya Karya (Persero) Tbk. (WIKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Wijaya Karya (Persero) Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Wijaya Karya (Persero) Tbk. trades at Rp204 (market cap 8.13T). The key difference: Wijaya Karya (Persero) Tbk. is far larger — about 77.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WIKA | |
|---|---|---|
Market Cap | 104.4B | 8.13T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Wijaya Karya (Persero) Tbk.
PT Wijaya Karya (Persero) Tbk (Perseroan) established under Act No. 19 of 1960 jo Government Regulation No. 64 year 1961 on Establishment of State Company/PN Widjaja Karja March 29, 1961. Based on Government Regulation No. 64, the building company previously owned by Dutch named Naamloze Vennootschap Technische Handel Maatschappij en Bouwbedrijf Vis en Co. which has been subject to nationalization, was merged into the PN Widjaja Karja.Based on Goverment Regulation No. 40 dated July 22, 1971 PN. Widjaja Karja declared dissolved and transformed into Limited Liability Company (PERSERO).
Read more on WIKA →
